MAOIs - does the evidence warrant their resurrection?
CONCLUSIONS: Sufficient evidence supports consideration of MAOIs in treatment-refractory and atypical depressive disorders, and in social anxiety disorder. Psychiatrists in training need to gain experience in using these agents.
PMID: 26917855 [PubMed - as supplied by publisher]
Source: Australasian Psychiatry - Category: Psychiatry Authors: Menkes DB, Bosanac P, Castle DJ Tags: Australas Psychiatry Source Type: research
More News: Anxiety | Bipolar | Databases & Libraries | Depression | Mania | Men | Nutrition | Psychiatry | Social Anxiety Disorder | Toxicology | Training | Universities & Medical Training